Advertisement

Breast Cancer pp 285-294 | Cite as

Axillary Node Dissection in Breast Cancer

  • James F. PingpankJr.
  • Elin R. Sigurdson
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

Axillary node dissection has been part of standard therapy for early breast cancer for more than a century. Since Fisher proposed that most breast cancers have spread before their detection, there has been controversy surrounding whether axillary node dissection is necessary in the treatment of early breast cancer. A trend toward less radical surgery and the possibility that axillary node involvement represents only a marker for distant disease has led many to believe that sampling the axilla is adequate and that full axillary dissection need not be performed. Reliable identification of the first node draining the tumor (the sentinel node), better pathologic staging of the primary tumor, more aggressive use of chemotherapy, and detection of smaller and smaller lesions have all contributed to the controversy.

Keywords

Breast Cancer Sentinel Node Sentinel Node Biopsy Axillary Node Axillary Node Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    le Dran F (1757) Memoire avec un precis de plusieurs observations sur le cancer. Mem. Acad. R. Chir. Paris 3, 1–56.Google Scholar
  2. 2.
    Petit JL (1837) Oeuvres Completes, section VII. R. Chapoulard, Limoges, pp. 438–445.Google Scholar
  3. 3.
    Robinson JO (1985) Treatment of breast cancer through the ages. Am. J. Surg. 151, 317–333.CrossRefGoogle Scholar
  4. 4.
    Wagner FB, Martin RG, Bland KI (1998) History of the therapy of breast disease. In: Bland KI, Copeland EM (eds.) The Breast: Comprehensive Management of Benign and Malignant Diseases, 2nd ed. WB Saunders, Philadelphia.Google Scholar
  5. 5.
    Halstead WS (1894–1895) The results of operations for cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp. Rep. 4, 297–350.Google Scholar
  6. 6.
    Urban JA, Baker HW (1952) Radical mastectomy in continuity with en-bloc resection of the internal mammary lymph node chain. Cancer 5, 992–1008.PubMedCrossRefGoogle Scholar
  7. 7.
    Nemoto T, Vana J, Bedwani RN, et al. (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45, 2917–2924.PubMedCrossRefGoogle Scholar
  8. 8.
    Patey DH, Dyson WH (1948) The prognosis of carcinoma of the breast in relation to the type of operation performed. Br. J. Cancer 2, 7–13.PubMedCrossRefGoogle Scholar
  9. 9.
    McWhirter R (1948) The value of simple mastectomy and radiotherapy in the treatment of cancer of the breast. Br. J. Radiol. 21, 599–610.PubMedCrossRefGoogle Scholar
  10. 10.
    Fisher B, Bauer M, Margolese R, et al. (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N. Engl. J. Med. 312, 665–673.PubMedCrossRefGoogle Scholar
  11. 11.
    Cady B, Stone MD, Schuler JG, et al. (1996) The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch. Surg. 131, 301–308.PubMedCrossRefGoogle Scholar
  12. 12.
    Silverstein MJ, Gierson ED, Waisman JR, et al. (1994) Axillary lymph node dissection for Tla breast carci noma. Is it indicated? Cancer 73, 664–667.PubMedCrossRefGoogle Scholar
  13. 13.
    Fein DA, Fowble BA, Hanlon AL, et al. (1997) Identification of women with T1–T2 breast cancer at low risk of positive axillary nodes. J. Surg. Oncol. 65, 34–39.PubMedCrossRefGoogle Scholar
  14. 14.
    Barth A, Craig PH, Silverstein MJ (1997) Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79, 1918–1922.PubMedCrossRefGoogle Scholar
  15. 15.
    White RE, Vezeridis MP, Konstadoulakis M, et al. (1996) Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of Tla and Tlb lesions. J. Am. Coll. Surg. 183, 575–582.PubMedGoogle Scholar
  16. 16.
    Port EP, Tan LK, Borgen PI, Van Zee KJ (1998) Incidence of axillary lymph node metastases in TI a and Tlb breast carcinoma. Ann. Surg. Oncol. 5, 23–27.PubMedCrossRefGoogle Scholar
  17. 17.
    McGee JM, Youmans R, Clingan F, et al. (1996) The value of axillary dissection in Tla breast cancer. Am. J. Surg. 72, 501–505.CrossRefGoogle Scholar
  18. 18.
    Olivotto IA, Jackson JS, Mates D, et al. (1998) Prediction of axillary lymph node involvement of women with invasive breast cancer. Cancer 83, 948–955.PubMedCrossRefGoogle Scholar
  19. 19.
    Ravdin PM, DeLaurentiis M, Vendely T, Clark GM (1994) Prediction of axillary node status in breast cancer patients by use of prognostic indicators. J. Natl. Cancer Inst. 86, 1771–1775.PubMedCrossRefGoogle Scholar
  20. 20.
    Fiegelson BJ, Acosta JA, Feigelson HS, et al. (1996) T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection. Am. J. Surg. 172, 487–490.CrossRefGoogle Scholar
  21. 21.
    Danforth D, Findlay P, McDonald H, et al. (1986) Complete axillary lymph node dissection for stage I–II carcinoma of the breast. J. Clin. Oncol. 4, 655–662.PubMedGoogle Scholar
  22. 22.
    Fisher ER, Sass R, Fisher B, et al. (1984) Pathologic findings from the National Surgical Adjuvant Project for breast cancers. Cancer 53, 712–723.PubMedCrossRefGoogle Scholar
  23. 23.
    Walsh R, Kornguth PJ, Soo MS, et al. (1996) Axillary lymph nodes: mammographic, pathologic, and clinical correlation. AJR 168, 33–38.CrossRefGoogle Scholar
  24. 24.
    Hata Y, Ogawa Y, Nishioka A (1996) Evaluation of thin section CT scanning in the prone position of metastatic axillary lymph nodes for breast cancer. Nippon Igaku Hoshasen Gakki Zasshi 56, 1027–1031.PubMedGoogle Scholar
  25. 25.
    Isaacs RJ, Ford JM, Allan SG, et al. (1993) Role of computed tomography in the staging of primary breast cancer. Br. J. Surg. 80, 1137.PubMedCrossRefGoogle Scholar
  26. 26.
    Heiberg EV, Ferman WH, Herrmann VM, et al. (1996) Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn. Reson. Imaging 14, 337–348.PubMedCrossRefGoogle Scholar
  27. 27.
    Nieweg OE, Kim EE, Wong WH, et al. (1993) Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 71, 3920–3925.PubMedCrossRefGoogle Scholar
  28. 28.
    Schnider K, Scharl A, Pietryzk U, et al: (1996) Qualitative [18F] FDG positron emission tomography in breast cancer: clinical relevance and practicability. Eur. J. Nucl. Med. 23, 618–623.CrossRefGoogle Scholar
  29. 29.
    Iyer R, Hanlon AL, Fowble B, et al. Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved, and number of nodes examined. Int. J. Radiat. Oncol. Biol. Phys. 47, 1177–1183.Google Scholar
  30. 30.
    Cabanas R (1977) An approach to the treatment of penile carcinoma. Cancer 39, 456–466.PubMedCrossRefGoogle Scholar
  31. 31.
    Morton DL, Wen DR, Wong JH, et al. (1992) Technical details of intraoperative lymphatic mapping of early stage melanoma. Arch. Surg. 127, 392–399.PubMedCrossRefGoogle Scholar
  32. 32.
    Krag DN, Weaver DL, Alex JC, et al. (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 2, 33–340.CrossRefGoogle Scholar
  33. 33.
    Giuliano AE, Kirgan DM, Guenther JM, et al. (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220, 391–401.PubMedCrossRefGoogle Scholar
  34. 34.
    Krag D, Weaver D, Ashikaga T, et al. (1998) The sentinel node in breast cancer: a multicenter validation study. N. Engl. J. Med. 339, 941–946.PubMedCrossRefGoogle Scholar
  35. 35.
    Morrow M (1996) Axillary dissection: when and how radical? Semin. Surg. Oncol. 12, 321–327.PubMedCrossRefGoogle Scholar
  36. 36.
    Fisher B, Wolmark N, Redmond C, et al. (1981) Findings of the NSABP Protocol No. B-04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 48, 1863–1872.PubMedCrossRefGoogle Scholar
  37. 37.
    Fisher B, Redmond C, Fisher E, et al. (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N. Engl. J. Med. 312, 674–681.PubMedCrossRefGoogle Scholar
  38. 38.
    Fisher B, Wolmark N, Bauer M, et al. (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg. Gynecol. Obstet. 152, 765–772.PubMedGoogle Scholar
  39. 39.
    Deckers Pi (1991) Axillary dissection in breast cancer; when, why, how, much, and for how long? Another operation soon to be extinct? J. Surg. Oncol. 48, 217–219.PubMedCrossRefGoogle Scholar
  40. 40.
    Lythoge J, Palmer M (1982) Manchester regional breast study-5 and 10 year results. Br. J. Surg. 69, 639–636.Google Scholar
  41. 41.
    Crile G (1964) Results of simplified treatment of breast cancer. Surg. Gynecol. Obstet. 517–523.Google Scholar
  42. 42.
    Forrest A, Stewart H, Steele R, et al. (1982) Simple mastectomy and axillary node sampling in the management of primary breast cancer. Ann. Surg. 196, 371–378.PubMedCrossRefGoogle Scholar
  43. 43.
    Gardner B, Feldman J (1993) Are positive axillary nodes in breast cancer markers for incurable disease? Ann. Surg. 218, 270–278.PubMedCrossRefGoogle Scholar
  44. 44.
    Harris J, Osteen R (1985) Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res. Treat. 5, 17–21.PubMedCrossRefGoogle Scholar
  45. 45.
    Cabanes PA, Salmon RJ, Vilcoq JR, et al. (1992) Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339, 1245–48.PubMedCrossRefGoogle Scholar
  46. 46.
    Orr RK (1999) The impact of prophylactic axillary node dissection on breast cancer survival—Bayesian meta-analysis. Ann. Surg. Oncol. 6, 109–116.PubMedCrossRefGoogle Scholar
  47. 47.
    Kuerer HM, Sahin AA, Hunt KK, et al. (1999) Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann. Surg. 230, 72–78.PubMedCrossRefGoogle Scholar
  48. 48.
    Roses DF, Brooks AD, Harris MN, et al. (1999) Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann. Surg. 230, 194–201.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • James F. PingpankJr.
  • Elin R. Sigurdson

There are no affiliations available

Personalised recommendations